Abstract
The vast figure of described molecular agents connected to pathogenesis could not be integrated easily or handled by traditional analytical procedures due to the exponential growth of highly sophisticated medical and scientific analysis tools over the past 30 years. In fact, the increased number of complicated diseases being defined has, in part, been caused by the recognition that various moieties represent disease markers. Thanks to currently accessible cutting-edge technology, scientists and doctors may now look into and evaluate any particular dysregulations occurring at the genomic, microRNA (miRNA), transcriptome, and protein levels. The fact that just isolated molecular levels are separately examined for its influence on each specific health condition presents a limitation in this scientific brave new world. Later its inception in the 1992 year, systems biology and remedy have mostly focused on the changes in complete route kinetics that lead to the beginning and/or worsening of the condition(s) under investigation. In order to shed light on a variety of study settings, systems medicine methodologies can be used. This has the practical benefit of revealing unique dynamic binding interactions that are crucial for affecting the progression of medical disorders. As a result, systems medicine helps to pinpoint clinically significant drug targets for preventative and curative actions against this illness.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albrecht E, Waldenberger M, Krumsiek J, Evans AM, Jeratsch U, Breier M, Adamski J, Koenig W, Zeilinger S, Fuchs C, Klopp N, Theis FJ, Wichmann H-E, Suhre K, Illig T, Strauch K, Peters A, Gieger C, Kastenmüller G, Meisinger C (2014) Metabolite profiling reveals new insights into the regulation of serum urate in humans. Metabolomics 10(1):141–151. https://doi.org/10.1007/s11306-013-0565-2
Andorf CM, Honavar V, Sen TZ (2013) Predicting the binding patterns of hub proteins: a study using yeast protein interaction networks. PLoS One 8(2):e56833. https://doi.org/10.1371/journal.pone.0056833
Araúzo-Bravo MJ (2016) Computational biology methods for characterization of pluripotent cells. Methods Mol Biol 1357:195–220. https://doi.org/10.1007/7651_2015_279
Babcock JJ, Du F, Xu K, Wheelan SJ, Li M (2013) Integrated analysis of drug-induced gene expression profiles predicts novel hERG inhibitors. PLoS One 8(7):e69513. https://doi.org/10.1371/journal.pone.0069513
Balazki P, Lindauer K, Einloft J, Ackermann J, Koch I (2015) MONALISA for stochastic simulations of petri net models of biochemical systems. BMC Bioinformatics 16(1):215. https://doi.org/10.1186/s12859-015-0596-y
Barbolosi D, Benabdallah A, Hubert F, Verga F (2009) Mathematical and numerical analysis for a model of growing metastatic tumors. Math Biosci 218(1):1–14. https://doi.org/10.1016/j.mbs.2008.11.008
Barnat J, Brim L, Černá I, Dražan S, Fabriková J, Láník J, Šafránek D, Ma H (2009) Bio DiVinE: a framework for parallel analysis of biological models. Electron Proceed Theor Comp Sci 6:31–45. https://doi.org/10.4204/EPTCS.6.3
Bartocci E, Lió P (2016) Computational modeling, formal analysis, and tools for systems biology. PLoS Comput Biol 12(1):e1004591. https://doi.org/10.1371/journal.pcbi.1004591
Benner S, Kakeyama M, Endo T, Yoshioka W, Tohyama C (2015) Application of neuro trace staining in the fresh frozen brain samples to laser microdissection combined with quantitative RT-PCR analysis. BMC Res Notes 8(1):252. https://doi.org/10.1186/s13104-015-1222-9
Benque D, Bourton S, Cockerton C, Cook B, Fisher J, Ishtiaq S, Piterman N, Taylor A, Vardi MY (2012) Bma: visual tool for modeling and analyzing biological networks. In: Madhusudan P, Seshia SA (eds) Computer aided verification, vol 7358. Springer, Berlin Heidelberg, pp 686–692. https://doi.org/10.1007/978-3-642-31424-7_50
Bolt MJ, Stossi F, Callison AM, Mancini MG, Dandekar R, Mancini MA (2015) Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity. Oncogene 34(2):154–164. https://doi.org/10.1038/onc.2013.550
Brazma A (2009) Minimum information about a microarray experiment (MIAME)–successes, failures, challenges. Sci World J 9:420–423. https://doi.org/10.1100/tsw.2009.57
Breitling R (2010) What is systems biology? Front Physiol 1:9. https://doi.org/10.3389/fphys.2010.00009
Breitling R, Gilbert D, Heiner M, Orton R (2008) A structured approach for the engineering of biochemical network models, illustrated for signalling pathways. Brief Bioinform 9(5):404–421. https://doi.org/10.1093/bib/bbn026
Bruggeman FJ, Westerhoff HV (2007) The nature of systems biology. Trends Microbiol 15(1):45–50. https://doi.org/10.1016/j.tim.2006.11.003
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611–622. https://doi.org/10.1373/clinchem.2008.112797
Çakır T, Khatibipour MJ (2014) Metabolic network discovery by top-down and bottom-up approaches and paths for reconciliation. Front Bioeng Biotechnol 2:1. https://doi.org/10.3389/fbioe.2014.00062
Cardinal-Fernández P, Nin N, Ruíz-Cabello J, Lorente JA (2014) Medicina de sistemas: Una nueva visión de la práctica clínica. Arch Bronconeumol 50(10):444–451. https://doi.org/10.1016/j.arbres.2013.10.010
Chen X, Liu M-X, Yan G-Y (2012) Drug–target interaction prediction by random walk on the heterogeneous network. Mol BioSyst 8(7):1970–1978. https://doi.org/10.1039/C2MB00002D
Cobanoglu MC, Liu C, Hu F, Oltvai ZN, Bahar I (2013) Predicting drug–target interactions using probabilistic matrix factorization. J Chem Inf Model 53(12):3399–3409. https://doi.org/10.1021/ci400219z
Costa J (2008) Systems medicine in oncology. Nat Clin Pract Oncol 5(3):117–117. https://doi.org/10.1038/ncponc1070
Cromar GL, Zhao A, Yang A, Parkinson J (2015) Hyperscape: visualization for complex biological networks. Bioinformatics 31(20):3390–3391. https://doi.org/10.1093/bioinformatics/btv385
de Graaf AA, Freidig AP, Roos BD, Jamshidi N, Heinemann M, Rullmann JAC, Hall KD, Adiels M, van Ommen B (2009) Nutritional systems biology modeling: from molecular mechanisms to physiology. PLoS Comput Biol 5(11):e1000554. https://doi.org/10.1371/journal.pcbi.1000554
Edwards LM, Thiele I (2013) Applying systems biology methods to the study of human physiology in extreme environments. Extrem Physiol Med 2(1):8. https://doi.org/10.1186/2046-7648-2-8
Faratian D, Clyde RG, Crawford JW, Harrison DJ (2009) Systems pathology—taking molecular pathology into a new dimension. Nat Rev Clin Oncol 6(8):455–464. https://doi.org/10.1038/nrclinonc.2009.102
Faruque J, Beaulieu CF, Rosenberg J, Rubin D, Yao D, Napel S (2015) Content-based image retrieval in radiology: analysis of variability in human perception of similarity. J Med Imaging (Bellingham) 2(2):025501. https://doi.org/10.1117/1.JMI.2.2.025501
Fouladiha H, Marashi S-A, Shokrgozar MA (2015) Reconstruction and validation of a constraint-based metabolic network model for bone marrow-derived mesenchymal stem cells. Cell Prolif 48(4):475–485. https://doi.org/10.1111/cpr.12197
Friboulet A, Thomas D (2005) Systems biology—an interdisciplinary approach. Biosens Bioelectron 20(12):2404–2407. https://doi.org/10.1016/j.bios.2004.11.014
Fu C, Jin G, Gao J, Zhu R, Ballesteros-villagrana E, Wong STC (2013) DrugMap central: an on-line query and visualization tool to facilitate drug repositioning studies. Bioinformatics 29(14):1834–1836. https://doi.org/10.1093/bioinformatics/btt279
Gay S, Soliman S, Fages F (2010) A graphical method for reducing and relating models in systems biology. Bioinformatics 26(18):i575–i581. https://doi.org/10.1093/bioinformatics/btq388
Giuliani A, Filippi S, Bertolaso M (2014) Why network approach can promote a new way of thinking in biology. Front Genet 5:83. https://doi.org/10.3389/fgene.2014.00083
Hillmer RA (2015) Systems biology for biologists. PLOS Pathog 11(5):e1004786. https://doi.org/10.1371/journal.ppat.1004786
Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, Kummer U (2006) COPASI—a COmplex PAthway SImulator. Bioinformatics 22(24):3067–3074. https://doi.org/10.1093/bioinformatics/btl485
Jin G, Wong STC (2014) Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today 19(5):637–644. https://doi.org/10.1016/j.drudis.2013.11.005
Jin G, Fu C, Zhao H, Cui K, Chang J, Wong STC (2012) A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Res 72(1):33–44. https://doi.org/10.1158/0008-5472.CAN-11-2333
Kalia M, Singh D, Sharma D, Narvi S, Agarwal V (2020) Senna alexandriana mill as a potential inhibitor for quorum sensing-controlled virulence factors and biofilm formation in Pseudomonas aeruginosa PAO1. Pharmacogn Mag 16(72):797. https://doi.org/10.4103/pm.pm_315_20
Kamada T (1992) System biomedicine: a new paradigm in biomedical engineering. Front Med Biol Eng 4(1):1–2
Karnes JH, Van Driest S, Bowton EA, Weeke PE, Mosley JD, Peterson JF, Denny JC, Roden DM (2014) Using systems approaches to address challenges for clinical implementation of pharmacogenomics. WIREs Syst Biol Med 6(2):125–135. https://doi.org/10.1002/wsbm.1255
Karp PD, Paley SM, Krummenacker M, Latendresse M, Dale JM, Lee TJ, Kaipa P, Gilham F, Spaulding A, Popescu L, Altman T, Paulsen I, Keseler IM, Caspi R (2010) Pathway tools version 13.0: integrated software for pathway/genome informatics and systems biology. Brief Bioinform 11(1):40–79. https://doi.org/10.1093/bib/bbp043
Kaushik AC, Sahi S (2015) Boolean network model for GPR142 against type 2 diabetes and relative dynamic change ratio analysis using systems and biological circuits approach. Syst Synth Biol 9(1):45–54. https://doi.org/10.1007/s11693-015-9163-0
Keene JD, Mesarovic MD, Sreenath SN (2004) Search for organising principles: understanding in systems biology. Syst Biol 1(1):19–27. https://doi.org/10.1049/sb:20045010
Kell DB (2007) The virtual human: towards a global systems biology of multiscale, distributed biochemical network models. IUBMB Life 59(11):689–695. https://doi.org/10.1080/15216540701694252
Kell DB (2013) Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it. FEBS J 280(23):5957–5980. https://doi.org/10.1111/febs.12268
Kell DB, Dobson PD, Bilsland E, Oliver SG (2013) The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discov Today 18(5):218–239. https://doi.org/10.1016/j.drudis.2012.11.008
Kidd BA, Peters LA, Schadt EE, Dudley JT (2014) Unifying immunology with informatics and multiscale biology. Nat Immunol 15(2):118–127. https://doi.org/10.1038/ni.2787
Kitano H (2002) Systems biology: a brief overview. Science 295(5560):1662–1664. https://doi.org/10.1126/science.1069492
Lefever S, Hellemans J, Pattyn F, Przybylski DR, Taylor C, Geurts R, Untergasser A, Vandesompele J, RDML Consortium (2009) RDML: structured language and reporting guidelines for real-time quantitative PCR data. Nucleic Acids Res 37(7):2065–2069. https://doi.org/10.1093/nar/gkp056
Lehnert T, Timme S, Pollmächer J, Hünniger K, Kurzai O, Figge MT (2015) Bottom-up modeling approach for the quantitative estimation of parameters in pathogen-host interactions. Front Microbiol 6:608. https://doi.org/10.3389/fmicb.2015.00608
Logan JA, Kelly ME, Ayers D, Shipillis N, Baier G, Day PJ (2010) Systems biology and modeling in neuroblastoma: practicalities and perspectives. Expert Rev Mol Diagn 10(2):131–145. https://doi.org/10.1586/erm.10.4
Majumder D, Mukherjee A (2011) A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer. Analyst 136(4):663–678. https://doi.org/10.1039/C0AN00746C
Mani KM, Lefebvre C, Wang K, Lim WK, Basso K, Dalla-Favera R, Califano A (2008) A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol Syst Biol 4(1):169. https://doi.org/10.1038/msb.2008.2
Mestdagh P, Lefever S, Pattyn F, Ridzon D, Fredlund E, Fieuw A, Ongenaert M, Vermeulen J, De Paepe A, Wong L, Speleman F, Chen C, Vandesompele J (2011) The microRNA body map: dissecting microRNA function through integrative genomics. Nucleic Acids Res 39(20):e136. https://doi.org/10.1093/nar/gkr646
Müssel C, Hopfensitz M, Kestler HA (2010) BoolNet—an R package for generation, reconstruction and analysis of Boolean networks. Bioinformatics 26(10):1378–1380. https://doi.org/10.1093/bioinformatics/btq124
Navin NE (2015) Delineating cancer evolution with single-cell sequencing. Sci Transl Med 7(296):296fs29. https://doi.org/10.1126/scitranslmed.aac8319
Nobile MS, Cazzaniga P, Tangherloni A, Besozzi D (2017) Graphics processing units in bioinformatics, computational biology and systems biology. Brief Bioinform 18:870–885
Pakladok T, Hosseinzadeh Z, Almilaji A, Lebedeva A, Shumilina E, Alesutan I, Lang F (2014) Up-regulation of hERG K+ channels by B-RAF. PLoS One 9(1):e87457. https://doi.org/10.1371/journal.pone.0087457
Raue A, Steiert B, Schelker M, Kreutz C, Maiwald T, Hass H, Vanlier J, Tönsing C, Adlung L, Engesser R, Mader W, Heinemann T, Hasenauer J, Schilling M, Höfer T, Klipp E, Theis F, Klingmüller U, Schöberl B, Timmer J (2015) Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems. Bioinformatics 31(21):3558–3560. https://doi.org/10.1093/bioinformatics/btv405
Rehman S, Salway F, Stanley JK, Ollier WER, Day P, Bayat A (2008) Molecular phenotypic descriptors of Dupuytren’s disease defined using informatics analysis of the transcriptome. J Hand Surg Am 33(3):359–372. https://doi.org/10.1016/j.jhsa.2007.11.010
Rehman S, Goodacre R, Day PJ, Bayat A, Westerhoff HV (2011) Dupuytren’s: a systems biology disease. Arthritis Res Ther 13(5):238. https://doi.org/10.1186/ar3438
Rehman S, Day P, Bayat A, Westerhoff H (2012) Understanding Dupuytren’s disease using systems biology: a move away from reductionism. Front Physiol 3:316. https://doi.org/10.3389/fphys.2012.00316
Rolfsson Ó, Palsson BO (2015) Decoding the jargon of bottom-up metabolic systems biology. BioEssays 37(6):588–591. https://doi.org/10.1002/bies.201400187
Sarmady M, Dampier W, Tozeren A (2011) Sequence- and interactome-based prediction of viral protein hotspots targeting host proteins: a case study for HIV Nef. PLoS One 6(6):e20735. https://doi.org/10.1371/journal.pone.0020735
Schramm HC, Dimitrov NB (2014) Differential equation models for sharp threshold dynamics. Math Biosci 247:27–37. https://doi.org/10.1016/j.mbs.2013.10.009
Sharma N, Singh D, Rani R, Sharma D, Pandey H, Agarwal V (2019) Chitosan and its nanocarriers: applications and opportunities. In: Nanomaterials in plants, algae and microorganisms. Academic Press, pp 267–286. https://doi.org/10.1016/B978-0-12-811488-9.00013-5
Singh D, Agarwal V (2022) An in vivo acute toxicity and anti-shigellosis effect of designed formulation on rat. J Ayurveda Integr Med 14:100536. https://doi.org/10.1016/j.jaim.2021.100536; Advance online publication
Singh D, Agarwal V (2022d) Herbal antibacterial remedy against upper respiratory infection causing bacteria and in vivo safety analysis. Vegetos 35(1):264–268. https://doi.org/10.1007/s42535-021-00281-3
Singh D, Sharma D, Agarwal V (2021) Screening of anti-microbial, anti-biofilm activity, and cytotoxicity analysis of a designed polyherbal formulation against shigellosis. J Ayurveda Integr Med 12(4):601–606. https://doi.org/10.1016/j.jaim.2021.06.007
Singh D, Pandey H, Shrivastava NK, Das R, Singh V (2022) Green synthesized gold and silver nanoparticles for antimicrobial applications. In: Baskar C, Ramakrishna S, Daniela La Rosa A (eds) Encyclopedia of green materials. Springer, Singapore. https://doi.org/10.1007/978-981-16-4921-9_254-1
Singh V, Pandey H, Misra V, Tiwari V, Srivastava P, Singh D (2022a) Hypolipidemic effect of [6]-Gingerol-loaded Eudragit polymeric nanoparticles in high-fat diet-induced rats and gamma scintigraphy evaluation of gastric-retention time. J Appl Pharm Sci 12(6):156–163. https://doi.org/10.7324/JAPS.2022.120615
Singh D, Singh V, Bhushan Mishra S, Sharma D, Agarwal V (2022b) Evaluation of anti-biofilm, anti-quorum, anti-dysenteric potential of designed polyherbal formulation: in vitro and in vivo study. J Appl Biomed 20(1):7–14. https://doi.org/10.32725/jab.2022.005
Singh D, Pandey H, Singh V (2022c) Natural products that target cancer stem cells. In: Handbook of research on natural products and their bioactive compounds as cancer therapeutics. IGI Global, pp 169–186. https://doi.org/10.4018/978-1-7998-9258-8.ch008
Singh D, Pandey H, Singh V, Pandey D (2023) The role of IoT in healthcare services: an extensive review. In: Internet of things and data mining for modern engineering and healthcare applications, pp 1–14. https://doi.org/10.1201/9781003217398
Sobie EA (2011) An introduction to dynamical systems. Sci Signal 4(191):tr6. https://doi.org/10.1126/scisignal.2001982
Sobie EA, Lee Y-S, Jenkins SL, Iyengar R (2011) Systems biology—biomedical modeling. Sci Signal 4(190):tr2. https://doi.org/10.1126/scisignal.2001989
Stevens A, Leonibus CD, Hanson D, Dowsey AW, Whatmore A, Meyer S, Donn RP, Chatelain P, Banerjee I, Cosgrove KE, Clayton PE, Dunne MJ (2014) Network analysis: a new approach to study endocrine disorders. J Mol Endocrinol 52(1):R79–R93. https://doi.org/10.1530/JME-13-0112
Tang J, Aittokallio T (2014) Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles. Curr Pharm Des 20(1):23–36
Tillmann T, Gibson AR, Scott G, Harrison O, Dominiczak A, Hanlon P (2015) Systems medicine 2.0: potential benefits of combining electronic health care records with systems science models. J Med Internet Res 17(3):e3082. https://doi.org/10.2196/jmir.3082
Verma M, Karimiani EG, Byers RJ, Rehman S, Westerhoff HV, Day PJR (2013) Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia Vis-a-Vis therapeutic strategies. Integr Biol 5(3):543–554. https://doi.org/10.1039/c3ib20230e
Wolstencroft K, Owen S, Krebs O, Nguyen Q, Stanford NJ, Golebiewski M, Weidemann A, Bittkowski M, An L, Shockley D, Snoep JL, Mueller W, Goble C (2015) SEEK: a systems biology data and model management platform. BMC Syst Biol 9(1):33. https://doi.org/10.1186/s12918-015-0174-y
Zhang S-Q, Ching W-K, Tsing N-K, Leung H-Y, Guo D (2010) A new multiple regression approach for the construction of genetic regulatory networks. Artif Intell Med 48(2):153–160. https://doi.org/10.1016/j.artmed.2009.11.001
Zhang W, Edwards A, Fan W, Flemington EK, Zhang K (2012) MiRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes. PLoS One 7(6):e40130. https://doi.org/10.1371/journal.pone.0040130
Zhao S, Nishimura T, Chen Y, Azeloglu EU, Gottesman O, Giannarelli C, Zafar MU, Benard L, Badimon JJ, Hajjar RJ, Goldfarb J, Iyengar R (2013) Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med 5(206):206ra140. https://doi.org/10.1126/scitranslmed.3006548
Zou J, Zheng M-W, Li G, Su Z-G (2013) Advanced systems biology methods in drug discovery and translational biomedicine. Biomed Res Int 2013:e742835. https://doi.org/10.1155/2013/742835
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singh, D., Shyam, P., Verma, S.K., Anjali (2024). Medical Applications of Systems Biology. In: Joshi, S., Ray, R.R., Nag, M., Lahiri, D. (eds) Systems Biology Approaches: Prevention, Diagnosis, and Understanding Mechanisms of Complex Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-99-9462-5_3
Download citation
DOI: https://doi.org/10.1007/978-981-99-9462-5_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-9461-8
Online ISBN: 978-981-99-9462-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)